Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: Impact of bacterial strain and antibiotic concentration

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 1, 2002, Pages 59-61

  Pendland, Susan L ^a   Neuhauser, Melinda M ^b   Garey, Kevin W ^b   Prause, Jennifer L ^a   Jung, Rose ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG EFFICACY; ENTEROBACTERIACEAE; IN VITRO STUDY; LEGIONELLA PNEUMOPHILA; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; BLOOD BACTERICIDAL ACTIVITY; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0036743885     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00422-4     Document Type: Article

References (10)

1. Debbia E., Schito G.C., Nicoletti G., Speciale A. In vitro activity of pefloxacin against Gram-negative and Gram-positive bacteria in comparison with other antibiotics. Chemioterapia. 4:1987;319-323.
2. Fung-Tomc J.C., Gradelski E., Valera L., Kolek B., Bonner D.P. Comparative killing rates of fluoroquinolones and cell wall-active agents. Antimicrobial Agents and Chemotherapy. 44:2000;1377-1380.
3. Gradelski E., Benjamin K., Bonner D., Fung-Tomc J. Bactericidal mechanism of gatifloxacin compared with other fluoroquinolones. Journal of Antimicrobial Chemotherapy. 49:2002;185-188.
4. Hoellman D.B., Lin G., Jacobs M.R., Appelbaum P.C. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. Journal of Antimicrobial Chemotherapy. 43:1999;645-649.
5. Lewin C.S. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628. Journal of Medical Microbiology. 36:1992;353-357.
6. Morrissey I. Bactericidal index a new way to assess quinolone bactericidal activity in vitro . Journal of Antimicrobial Chemotherapy. 39:1997;713-717.
7. National Committee for Clinical Laboratory Standards . Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. 2001;. NCCLS document M100-S11. Wayne, PA.
8. National Committee for Clinical Laboratory Standards . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. 2000;NCCLS, Wayne, PA. Approved standard M7-A5.
9. National Committee for Clinical Laboratory Standards . Methods for determining bactericidal activity of antimicrobial agents. 1999;NCCLS, Wayne, PA. Approved Guideline M26-A.
10. Ristroph J.D., Hedlund K.W., Allen R.G. Liquid medium for growth of Legionella pneumophila. Journal of Clinical Microbiology. 11:1980;19-21.